☆ 4.6 Article

SETD3 Methyltransferase Regulates PLK1 Expression to Promote In Situ Hepatic Carcinogenesis

FRONTIERS IN ONCOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Cell Biology

Cell cycle on the crossroad of tumorigenesis and cancer therapy

Jing Liu et al.

Summary: Cell cycle aberrancy is a fundamental mechanism underlying tumorigenesis, and therapies targeting cell cycle machinery components can not only suppress cancer cell division but also reverse cancer metabolism and restore cancer immune surveillance. Recently, proteolysis targeting chimeras (PROTACs) have been used to target oncogenic proteins related to cell cycle progression for more effective tumor suppression.

TRENDS IN CELL BIOLOGY (2022)

添加到收藏夹

Article Oncology

Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma

Weiqiang Fan et al.

Summary: This study found that FOXM1 and PLK1 were overexpressed in HCC tumor tissues, and their coordinated overexpression was associated with poor prognosis of patients with HCC.

ONCOLOGY LETTERS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Elevated METTL9 is associated with peritoneal dissemination in human scirrhous gastric cancers

Toshifumi Hara et al.

Summary: Methyltransferase-like 9 (METTL9) plays a crucial role in the metastasis of scirrhous gastric cancer. Its elevated expression is closely associated with enhanced metastatic activity. Knockdown of METTL9 significantly inhibits migration and invasion of metastatic cells. METTL9 is predominantly localized in mitochondria in metastatic cells, and its knockdown reduces mitochondrial Complex I activity. Therefore, METTL9 may be a potential molecular target to inhibit peritoneal dissemination of scirrhous gastric cancer.

BIOCHEMISTRY AND BIOPHYSICS REPORTS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Deficiency of Histone Methyltransferase SET Domain-Containing 2 in Liver Leads to Abnormal Lipid Metabolism and HCC

Xue-Jing Li et al.

Summary: The study demonstrates that Setd2 deficiency can trigger spontaneous HCC by modulating DNA damage response and lipid metabolism in the liver. High-fat diet enhances lipid accumulation and promotes the development of HCC in Setd2-deficient mice.

HEPATOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

The methyltransferase SETD3-mediated histidine methylation: Biological functions and potential implications in cancers

Wen-Jie Shu et al.

Summary: SETD3 is a member of a family of proteins containing the SET domain, and it functions as a histidine methyltransferase catalyzing methylation of actin histidine 73. Recent research advances have focused on structural properties, substrate recognition features, and physiological functions, particularly highlighting the potential pathological relevance of SETD3 in human cancers.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Polo-like kinase 1 (PLK1) signaling in cancer and beyond

Styliani Iliaki et al.

Summary: PLK1 is a Ser/Thr kinase that plays crucial roles in cell cycle regulation, DNA damage response, apoptosis, and cancer progression. Overexpression of PLK1 is associated with poor prognosis in cancer, making it an attractive therapeutic target.

BIOCHEMICAL PHARMACOLOGY (2021)

添加到收藏夹

Review Oncology

Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease

Maria Arechederra et al.

Summary: Cellular identity and function are regulated by the correct expression of genetic information, which is controlled by various epigenetic mechanisms such as DNA methylation, histone modifications, and non-coding RNA expression. Abnormalities in these mechanisms are associated with the development of multiple diseases. Chronic liver disease, including hepatocellular carcinoma, is on the rise globally, but management of these patients is challenging due to late diagnosis and lack of effective therapies. Understanding and targeting epigenetic alterations may provide new therapeutic strategies and diagnostic tools for these diseases.

CANCERS (2021)

添加到收藏夹

Review Oncology

The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma

Fang Wang et al.

Summary: This article summarizes the current understanding of epigenetic regulation in the HCC microenvironment and reviews recent studies on the role of specific epigenetic mechanisms in HCC development.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Letter Cell Biology

METTL9 mediated N1-histidine methylation of zinc transporters is required for tumor growth

Mengyue Lv et al.

PROTEIN & CELL (2021)

添加到收藏夹

Article Oncology

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma

Tian-Hao Li et al.

Summary: METTL18 high expression is associated with poor clinicopathological characteristics and prognosis in HCC, as well as immune cell infiltration. Furthermore, analysis such as Gene Set Enrichment Analysis revealed potential regulatory mechanisms of METTL18 in HCC.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Review Oncology

The language of chromatin modification in human cancers

Shuai Zhao et al.

Summary: The deregulation of chromatin modification underlies numerous oncogenic processes, contributing to cancer development by inducing epigenetic, transcriptomic, and phenotypic alterations. Understanding and developing more effective drugs to target these chromatin-related vulnerabilities will enhance the treatment of human malignancies. This review synthesizes the connections between chromatin modifications and cancer, highlighting options for therapeutic targeting based on recent advances.

NATURE REVIEWS CANCER (2021)

添加到收藏夹

Review Oncology

Immunotherapy for hepatocellular carcinoma

Yin Zongyi et al.

CANCER LETTERS (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Advances in molecular classification and precision oncology in hepatocellular carcinoma

Sandra Rebouissou et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

PLK1/NF-κB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression

Lantian Tian et al.

ONCOGENE (2020)

添加到收藏夹

Article Oncology

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry

Hanna Engqvist et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells

Nourhan Hassan et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Cell Biology

CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma

Ling Li et al.

CELL CYCLE (2020)

添加到收藏夹

Article Immunology

Overexpression of CXCR5 in CD4+ T cells of SLE patients caused by excessive SETD3

Jieyue Liao et al.

CLINICAL IMMUNOLOGY (2020)

添加到收藏夹

Article Cell Biology

SETD3 is a positive regulator of DNA-damage-induced apoptosis

Elina Abaev-Schneiderman et al.

CELL DEATH & DISEASE (2019)

添加到收藏夹

Review Medicine, General & Internal

Hepatocellular Carcinoma

Augusto Villanueva

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets

Daniel Neureiter et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy

Qingmei Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Ju Dong Yang et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

添加到收藏夹

Article Medicine, Research & Experimental

SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma

Liangliang Xu et al.

CLINICAL SCIENCE (2019)

添加到收藏夹

Article Multidisciplinary Sciences

SETD3 is an actin histidine methyltransferase that prevents primary dystocia

Alex W. Wilkinson et al.

NATURE (2019)

添加到收藏夹

Article Cell Biology

Comprehensive and Integrative Analysis Reveals the Diagnostic, Clinicopathological and Prognostic Significance of Polo-Like Kinase 1 in Hepatocellular Carcinoma

Peng Lin et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Epigenetic Regulation of HCC Metastasis

Tae-Su Han et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

添加到收藏夹

Article Biology

SETD3 protein is the actin-specific histidine N-methyltransferase

Sebastian Kwiatkowski et al.

ELIFE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis

Xiaoqing Cheng et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

PLK-1: Angel or devil for cell cycle progression

Shiv Kumar et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)

添加到收藏夹

Review Pathology

Molecular interactions of polo-like kinase 1 in human cancers

Wayne Tiong Weng Ng et al.

JOURNAL OF CLINICAL PATHOLOGY (2016)

添加到收藏夹

Review Oncology

Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics

Rosie Elizabeth Ann Gutteridge et al.

MOLECULAR CANCER THERAPEUTICS (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Chromatin associated SETD3 negatively regulates VEGF expression

Ofir Cohn et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication

Ana Silvia Pires-Luis et al.

EPIGENETICS (2015)

添加到收藏夹

Review Pathology

Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research

Xin Chen et al.

AMERICAN JOURNAL OF PATHOLOGY (2014)

添加到收藏夹

Article Cell Biology

The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers

R. Sumanth Iyer et al.

CELL CYCLE (2014)

添加到收藏夹

Article Oncology

p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex

Zhe Zhou et al.

EXPERIMENTAL CELL RESEARCH (2013)

添加到收藏夹

Article Hematology

The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis

Zhangguo Chen et al.

HAEMATOLOGICA (2013)

添加到收藏夹

Article Oncology

Reduced Efficacy of the Plk1 Inhibitor BI 2536 on the Progression of Hepatocellular Carcinoma due to Low Intratumoral Drug Levels

Jorg Haupenthal et al.

NEOPLASIA (2012)

添加到收藏夹

Article Biochemistry & Molecular Biology

Characterization of a Novel Histone H3K36 Methyltransferase setd3 in Zebrafish

Dong-Wook Kim et al.

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Histone Methyltransferase SETD3 Regulates Muscle Differentiation

Gwang Hyeon Eom et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Oncogenic and Tumor Suppressive Roles of Polo-Like Kinases in Human Hepatocellular Carcinoma

Rossella Pellegrino et al.

HEPATOLOGY (2010)

添加到收藏夹

Review Gastroenterology & Hepatology

Experimental models of hepatocellular carcinoma

Philippa Newell et al.

JOURNAL OF HEPATOLOGY (2008)

添加到收藏夹

Article Cell Biology

Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression

Zheng Fu et al.

NATURE CELL BIOLOGY (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.